Related Experiment Video

Updated: May 9, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas

R Eskinazi1, A Resibois, M Svoboda

  • 1Laboratoire de Chimie Biologique et de la Nutrition, Faculté de Médicine, Hôpital Erasme, Université Libre de Bruxelles, Belgium.

Gastroenterology
|June 3, 1998
PubMed
Abstract

Insights

Sporadic colorectal cancers show overexpression of TGF-beta receptors, but lack mutations in these receptors. This suggests different tumorigenesis pathways compared to hereditary cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Transforming growth factor (TGF)-beta is a key regulator of cell growth.
  • Resistance to TGF-beta's growth-inhibitory effects in cancer is a significant clinical challenge.
  • Mutations in TGF-beta receptors have been implicated in some colorectal cancers, suggesting a potential mechanism for resistance.

Purpose of the Study:

  • To investigate the expression and distribution of TGF-beta receptors (type I and type II) in sporadic colorectal cancers.
  • To determine if mutations in the microsatellite-like regions of the type II TGF-beta receptor are present in sporadic colorectal cancers.
  • To correlate receptor expression and mutations with tumor characteristics.

Main Methods:

  • Immunohistochemistry was used to assess TGF-beta receptor expression in 33 sporadic colorectal cancers and 20 normal colonic tissues.
  • Radioactive thermocycling and sequencing were performed on microsatellite-like regions of the type II receptor in 18 tumor and 20 normal samples.
  • Statistical analysis was employed to correlate receptor findings with tumor differentiation, Dukes' staging, and localization.

Main Results:

  • Both type I and type II TGF-beta receptors were found to be overexpressed in tumor tissues compared to normal tissues.
  • A positive correlation was observed between the level of type II receptor expression and the degree of tumor differentiation.
  • No mutations were detected in the microsatellite-like regions of the type II receptor in any of the analyzed sporadic colorectal cancer samples.

Conclusions:

  • The absence of mutations in TGF-beta receptors in sporadic colorectal cancers indicates that this mechanism does not explain resistance to TGF-beta-mediated growth inhibition in these tumors.
  • The findings suggest that the molecular pathways driving tumorigenesis in sporadic colorectal cancers may differ from those in hereditary forms.
  • Overexpression of TGF-beta receptors in sporadic colorectal cancers warrants further investigation into their role in tumor progression.

More Related Videos

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 13, 2013

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...